Assembly Biosciences, Inc.

ASMB Nasdaq SEC CIK 1426800
Follow Assembly Biosciences Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $3M −72.6% vs same quarter last year
Net income −$20.3M −120.3% vs same quarter last year
EPS, diluted −$0.93 −29.2% vs same quarter last year
Operating cash flow −$17.2M −13.4% vs same quarter last year
Revenue by quarter
$7.4M
$9.4M
$9.6M
$10.8M
$42.5M
$8.2M
$13.4M
$3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$72.3M−$6.1M
FY24$28.5M−$40.2M
FY23$7.2M−$61.2M
FY22$0−$93.1M
FY21$6.3M−$129.9M
FY20$79.1M−$62.2M
FY19$16M−$97.6M
FY18$14.8M−$90.8M
FY17$9M−$42.8M
FY16$0−$44.3M
FY15-−$28.5M
FY14-−$23.8M
FY13-−$19.4M
FY12-−$24.8M
FY11-−$34.3M
MarginsShare of revenue
  • Operating margin
  • Net margin
−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−16.8%−8.5%
FY24−159.3%−140.9%
FY23−902.5%−854.8%
FY22--
FY21−2121.7%−2076.4%
FY20−81.9%−78.6%
FY19−643.4%−611.6%
FY18−626.4%−613%
FY17−579.1%−474.7%
FY16--
FY15--
FY14--
FY13--
FY12--
FY11--
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$41.2M
FY24−$51.1M
FY23$22.5M
FY22−$84.6M
FY21−$96.5M
FY20−$63.4M
FY19−$85.6M
FY18−$65.3M
FY17$995K
FY16−$35M
FY15−$18.8M
FY14−$15.1M
FY13−$17.8M
FY12−$21.4M
FY11−$25.1M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Assembly Biosciences
  • Healthcare median
−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAssembly BiosciencesHealthcare median
FY25−8.5%−30.6%
FY24−140.9%−47%
FY23−854.8%−58%
FY22-−80.4%
FY21−2076.4%−71.8%
FY20−78.6%−62.2%
FY19−611.6%−46.2%
FY18−613%−49.6%
FY17−474.7%−45.9%
FY16-−36%
FY15-−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%